IMNR - Immune Response Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: poodle who wrote (1156)	11/10/1998 10:38:00 AM
From: jake burns	Read Replies (1) of 1510

A 2500 patient phase 3 trial is scheduled to end March '99. Also, another ph. 3 trial (for about 300 patients) will be initiated by agouron in the first quarter of 99 to test remune + viracept. This trial will last 12 months with an interim review at 6 months. It could be halted at that time.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next